Organoids with Vascularization and Immune Cells Launched by AIM Biotech

AIM Biotech, a Singapore- and Boston-based company, announced the launch of the organiX System—a lab tool to closely model human disease by adding vascularization and immune competence to organoids, spheroids, and tumor biopsies.